Cite
MLA Citation
Jumpei Teramachi et al.. “Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.” British journal of haematology, vol. 180, 2018, pp. 581–585. http://access.bl.uk/ark:/81055/vdc_100057290294.0x00005b